LOKELMA

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug LOKELMA contains one active pharmaceutical ingredient (API):

1	Sodium zirconium cyclosilicate UNII D652ZWF066 - SODIUM ZIRCONIUM CYCLOSILICATE
	Sodium zirconium cyclosilicate is a non-absorbed, non-polymer inorganic powder with a uniform micropore structure that preferentially captures potassium in exchange for hydrogen and sodium cations. Sodium zirconium cyclosilicate captures potassium throughout the entire gastrointestinal (GI) tract and reduces the concentration of free potassium in the GI lumen, thereby lowering serum potassium levels and increasing faecal potassium excretion to resolve hyperkalaemia.
	Read more about Sodium zirconium cyclosilicate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LOKELMA Powder for oral suspension	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V03AE10		V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02490714, 02490722
EE	Ravimiamet	1767573, 1767584, 1767595, 1767607, 1792841, 1792852
ES	Centro de información online de medicamentos de la AEMPS	1171173002, 1171173004
FI	Lääkealan turvallisuus- ja kehittämiskeskus	171874, 580788
FR	Base de données publique des médicaments	64247885, 64737437
GB	Medicines & Healthcare Products Regulatory Agency	370618, 370624, 370626
HK	Department of Health Drug Office	66489, 66490
IT	Agenzia del Farmaco	046335016, 046335028, 046335030, 046335042, 046335055, 046335067, 046335079, 046335081, 046335093, 046335105, 046335117, 046335129
JP	医薬品医療機器総合機構	2190040B1020, 2190040B2027
LT	Valstybinė vaistų kontrolės tarnyba	1085278, 1085279, 1085280, 1085281, 1085819, 1085820, 1088657, 1088658, 1088659, 1088660, 1088661, 1088662
NL	Z-Index G-Standaard, PRK	198498, 198501
PL	Rejestru Produktów Leczniczych	100423163, 100423170
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65518001, W65519001
US	FDA, National Drug Code	0310-1105, 0310-1110